Hepatopulmonary Syndrome
11
0
0
2
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
36.4%
4 terminated out of 11 trials
33.3%
-53.2% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Letrozole in Patients With Hepatopulmonary Syndrome
Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia
Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome
Sorafenib for Hepatopulmonary Syndrome
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China
Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study
A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome
Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome
Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome